Safety assessment of bone marrow derived MSC grown in platelet-rich plasma

The injection of endothelial progenitor cells and mononuclear cells derived from bone marrow at the ischemic region of peripheral artery disease patients is reported to be effective for therapeutic angiogenesis; however, these cell therapies require large amounts of bone marrow to obtain sufficient...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukuda, Shoji, Hagiwara, Shotaro, Fukuda, Satsuki, Yakabe, Ryo, Suzuki, Hiroko, Yabe, Shigeharu G., Chan, Techuan, Okochi, Hitoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society for Regenerative Medicine 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581768/
https://www.ncbi.nlm.nih.gov/pubmed/31245443
http://dx.doi.org/10.1016/j.reth.2015.02.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581768/
https://www.ncbi.nlm.nih.gov/pubmed/31245443
http://dx.doi.org/10.1016/j.reth.2015.02.001

Ejemplares similares